Investing $1,000 Into This Marijuana Stock in 2016 Would Leave You With Pennies on the Dollar TodayThe Motley Fool • 05/13/19
Insys Therapeutics (INSY) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/11/19
Insys Therapeutics founder, former executives found guilty in criminal fentanyl bribery caseCNBC • 05/02/19
Insys Therapeutics (INSY) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 03/29/19